Mutual Fund SIPs Over OneThird of 2Year Investments Show Losses Data Reveals Trump Urges Bank of America and JPMorgan to End Alleged Discrimination Against Conservative Clients Consumer Resilience Fuels Economic Optimism Amid Persistent Headwinds LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad Cipla Stock Trends Market Observes Recent Movement Amid Sector Dynamics European Firms Reindustrialise Amid Falling Investment Plans AI Emerges as Key Driver iQIYI Q1 2026 Earnings EPS Misses Estimates as Profitability Challenges Persist Park Dental Partners Inc PARK Q1 2026 Earnings EPS Smashes Estimates Stock Gains on Strong Operational Performance Axogen Q1 2026 Earnings EPS Misses Estimates Shares Slide on Slight Miss BE Q1 2026 Earnings Impressive EPS Beat Amidst Ongoing Investor Caution ICE Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet NVE Corporation NVEC Gains 268 as Technical Levels Signal Potential Upside Red Violet Inc RDVT Surges 428 Momentum Building Above Key Support Levels Alpha Tau Medical DRTS Slides 84 as Shares Test Support Levels Bitfarms Ltd BITF Holds Steady at 198 as Crypto Mining Sector Watches Key Levels Nuveen Dynamic Municipal Opportunities Fund NDMO Holds Steady Near 1030 as RangeBound Trading Persists Bank Nifty Outlook Analysts Eye Selective Opportunities as PSU Banks Face Margin Hurdles SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher AFLAC AFL Slides 165 as Broader Market Headwinds Weigh on Insurance Sector INFQ Q1 2026 Earnings Loss Per Share Widens Stock Surges on No Estimate Comparison FTI Q1 2026 Earnings EPS Surpasses Estimates by Nearly 12 LanzaTech Q4 2025 Earnings EPS Surprise of 8379 Despite Continued Losses 51Talk Q3 2025 Earnings EPS Misses Amid Narrowing Revenue Visibility and Stock Decline SSB Q1 2026 Earnings Slight EPS Beat Drives Modest Stock Uptick HUBS Q1 2026 Earnings EPS Surges Past Estimates Revenue Growth Remains in Focus HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress